DMARD


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to DMARD: ACR20

DMARD

Acronym for disease modifying antirheumatic drugs , under drug.

DMARD

DMARD

Abbreviation for disease-modifying antirheumatic drugs.

DMARD

Abbreviation for disease-modifying antirheumatic drugs.
References in periodicals archive ?
In SA, commencement of biologic therapy after a 6-month trial of at least 3 synthetic DMARDs (including MTX, unless contraindicated) seems reasonable, given resource constraints, and given that up to one-third of patients will achieve LDA on synthetic DMARD therapy.
A phase III, multicenter, double-blind, randomized, controlled withdrawal study was conducted with abatacept in 190 patients with active poly-JIA despite at least one DMARD.
Additionally, when adjusting for other risk factors for diabetes, researchers found a reduced relative risk of diabetes in patients treated with TNF inhibitors and hydroxychloroquine compared with other non-biologic DMARDs.
Yaslilarda DMARD etkilerine yonelik iyi veriler yetersiz duzeydedir; i yi metodoloji ve yeterli sayida hastayi iceren calismala ra gereksinim vardir.
In a large community-based study concerning the problem of risk perception and unwillingness to try another DMARD by RA patients, the patients "resistant to change" were significantly older, used fewer DMARDs before, had lower health literacy as well as higher perception of medication risk.
For patients who lose efficacy of multiple biologic agents, consider switching to combination DMARD therapy to avoid the issue of AABs.
Rigel believes that R406 may become a first-line DMARD with greater efficacy, safety and improved delivery and patient compliance than injectable treatments, and thus may be used early in the course of the disease before significant bone and cartilage damage occurs.
patients were required to be considered DMARD inadequate responders (IR) other than MTX, and 3.
We compared the effects of anti-TNF therapy on hemoglobin levels with that of DMARD therapy in the same patients before anti-TNF therapy.
4 cases per 1,000 person-years, an adjusted 36% lower risk than that in patients on a nonbiologic DMARD, ose rate was 6.
Early therapy with combinations of conventional DMARDs has been shown to retard the radiologic progression of RA for a period of up to 5 years, but until now the effects of initial aggressive DMARD therapy on radiologic prognosis after that were unknown.